论文部分内容阅读
目的观察脑出血急性期使用血塞通改善循环治疗的临床疗效。方法脑出血病人43例,随机分为治疗组和对照组,第一周两组均按脑出血常规治疗;治疗组在脑出血后第8天加用血塞通改善循环,治疗3周后,进行疗效及影像学评价。结果治疗前及治疗3周后神经功能缺损评分,治疗组为(22.25±8.72)分、(6.77±8.71)分;对照组为(21.02±10.4)分、(12.70±9.58)分。治疗前后血肿吸收情况,治疗组为(20.40±8.50)mL、(9.00±4.30)mL,对照组为(22.10±7.61)mL、(17.00±7.76)mL。结论脑出血急性期改善循环治疗能显著改善病人的临床症状,促进血肿吸收。
Objective To observe the clinical efficacy of Xuesaitong in improving circulation therapy in acute cerebral hemorrhage. Methods Forty-three patients with intracerebral hemorrhage were randomly divided into treatment group and control group. The first two weeks were treated by conventional cerebral hemorrhage. In the treatment group, Xuesaitong improved circulation on the eighth day after intracerebral hemorrhage. After three weeks of treatment, Efficacy and imaging evaluation. Results The score of neurological deficits before treatment and after 3 weeks of treatment were (22.25 ± 8.72) and (6.77 ± 8.71) in the treatment group and (21.02 ± 10.4) and (12.70 ± 9.58) points in the control group. The hematoma absorption before and after treatment was (20.40 ± 8.50) mL and (9.00 ± 4.30) mL in the treatment group and (22.10 ± 7.61) mL and (17.00 ± 7.76) mL in the control group, respectively. Conclusion The improvement of acute cerebral hemorrhage circulation treatment can significantly improve the clinical symptoms of patients and promote hematoma absorption.